A 4-Week, Randomized, Double-Blind, Cohort Study to Evaluate the Safety and Tolerability of Converting From Ropinirole Immediate Release (IR) to Ropinirole Controlled Release for RLS (CR-RLS) Formulation (Formerly Ropinirole Extended Release [XR]) in Patients With Restless Legs Syndrome (RLS)

This is a multi-center, Phase III study to evaluate the safety and tolerability of proposed dose conversion recommendations for RLS subjects converting from ropinirole immediate release to ropinirole controlled-release for RLS.

本研究为一项多中心III期临床试验，旨在评估不宁腿综合征（Restless Legs Syndrome, RLS）受试者将治疗药物从罗匹尼罗常释制剂（ropinirole immediate release）转换为罗匹尼罗控释制剂（ropinirole controlled-release）时，拟议剂量转换方案的安全性与耐受性。